Beckmann James T, Wylie James D, Kapron Ashley L, Hanson Joey A, Maak Travis G, Aoki Stephen K
University of Utah, Department of Orthopaedic Surgery, Salt Lake City, Utah, USA.
University of Utah, Department of Orthopaedic Surgery, Salt Lake City, Utah, USA
Am J Sports Med. 2014 Jun;42(6):1359-64. doi: 10.1177/0363546514526361. Epub 2014 Mar 24.
Heterotopic ossification (HO) is a known complication of hip arthroscopy. Little is known about the factors that lead to HO after hip arthroscopy.
The aim of this study was to evaluate the effect of nonsteroidal anti-inflammatory drugs (NSAIDs) and other operative variables on the development of HO.
Cohort study; Level of evidence, 3.
A total of 357 consecutive cases of hip arthroscopy were retrospectively reviewed over a 3-year period. Routine NSAID prophylaxis was not performed for the first 117 cases. Prophylaxis with naproxen for 3 weeks was then routinely prescribed for the remaining 240 cases. Complete follow-up was available for 288 of the original 357 cases. The presence of HO and its characteristics were recorded for each patient, along with baseline demographic and surgical variables. Odds ratios and logistic regression were used to identify causal factors for HO.
The incidence of HO in cases in which the patient did not receive NSAID prophylaxis was 25.0% (23/92) versus 5.6% (11/196) of cases in which the patient received NSAIDs. Patients who received no NSAID prophylaxis were 13.6 times more likely to develop HO postoperatively (95% confidence interval, 2.44-75.5; P = .003). Comparing just mixed-type femoroacetabular impingement resections, patients who received no NSAID prophylaxis were 16.6 times more likely to develop HO postoperatively (95% confidence interval, 2.2-126.0; P = .006). Multivariate logistic regression identified the performance of a mixed-type femoroacetabular impingement resection (P = .011) and the absence of NSAID prophylaxis (P = .003) as predictors of HO development. The majority of HO cases (29/34) occurred in patients with mixed-type femoroacetabular impingement who had both osteochondroplasty and acetabuloplasty. Complications of NSAID therapy in this study population included acute renal failure, hematochezia from acute colitis, and gastritis.
Routine NSAID prophylaxis reduces but does not eliminate the incidence of HO in patients undergoing hip arthroscopy. Heterotopic ossification was more likely to develop in patients undergoing acetabuloplasty along with osteochondroplasty and in those who did not receive prophylactic postoperative NSAIDs. Side effects from the investigated NSAID regimen can be serious and should be weighed against the potential benefits in preventing the formation of HO.
异位骨化(HO)是髋关节镜手术已知的并发症。关于髋关节镜手术后导致HO的因素知之甚少。
本研究的目的是评估非甾体类抗炎药(NSAIDs)和其他手术变量对HO发生发展的影响。
队列研究;证据等级,3级。
回顾性分析了3年期间连续357例髋关节镜手术病例。前117例患者未进行常规NSAIDs预防。随后对其余240例患者常规给予萘普生预防3周。357例原始病例中有288例获得了完整随访。记录了每位患者HO的存在情况及其特征,以及基线人口统计学和手术变量。采用比值比和逻辑回归分析来确定HO的病因。
未接受NSAIDs预防的患者中HO的发生率为25.0%(23/92),而接受NSAIDs预防患者的发生率为5.6%(11/196)。未接受NSAIDs预防的患者术后发生HO的可能性高13.6倍(95%置信区间,2.44 - 75.5;P = 0.003)。仅比较混合型股骨髋臼撞击症切除术,未接受NSAIDs预防的患者术后发生HO的可能性高16.6倍(95%置信区间,2.2 - 126.0;P = 0.006)。多因素逻辑回归分析确定混合型股骨髋臼撞击症切除术(P = 0.011)和未进行NSAIDs预防(P = 0.003)是HO发生发展的预测因素。大多数HO病例(29/34)发生在同时进行了骨软骨成形术和髋臼成形术的混合型股骨髋臼撞击症患者中。本研究人群中NSAIDs治疗的并发症包括急性肾衰竭、急性结肠炎便血和胃炎。
常规NSAIDs预防可降低但不能消除髋关节镜手术患者HO的发生率。在同时进行髋臼成形术和骨软骨成形术的患者以及未接受术后预防性NSAIDs治疗的患者中,异位骨化更易发生。所研究的NSAIDs治疗方案的副作用可能很严重,应权衡其在预防HO形成方面的潜在益处。